METHYLDOPA IN THE TREATMENT OF HYPERTENSION
- 14 April 1962
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 279 (7233), 763-768
- https://doi.org/10.1016/s0140-6736(62)91782-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- NEWER BIOCHEMICAL APPROACHES TO THE TREATMENT OF HYPERTENSIONAnnals of the New York Academy of Sciences, 1960
- Serotonin Synthesis in Carcinoid PatientsNew England Journal of Medicine, 1960
- CLINICAL AND PHARMACOLOGICAL STUDIES WITH GUANETHIDINE IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Hemmung der Serotoninbildung durch ?-Methyl-DopaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1958
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954